Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579020 · ClinicalTrials.gov registry record · Phase 2
A Phase II Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates
A Phase 2 study, sponsored by Alcon Research.
- Terminated
- Registry status
- Phase 2
- Development phase
- 144
- Enrollment target
NCT00579020: Clinical Trial Phase 2 study, sponsored by Alcon Research.
NCT00579020 is a Phase 2 study that was terminated before completion, run by Alcon Research. The registered enrollment target is 144 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00579020, a Phase 2 study, was terminated before completion, sponsored by Alcon Research.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 144 participants
- Enrollment target
Study Summary
The purpose of the study is to determine whether Moxidex ophthalmic solution is safe and effective in treating marginal corneal infiltrates.
Interventions
- DRUG Moxifloxacin/dexamethasone phosphate ophthalmic solution
- DRUG Moxifloxacin ophthalmic solution 0.5%
- DRUG Dexamethasone phosphate solution, 0.1%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2007-12 |
| Est. Completion | 2009-02 |
| Phase | Phase 2 |
Why NCT00579020 stopped before completion
NCT00579020 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Moxifloxacin/dexamethasone phosphate ophthalmic solution is the first listed.
NCT00579020 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00579020 about?
NCT00579020 is a clinical study titled "A Phase II Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates". The purpose of the study is to determine whether Moxidex ophthalmic solution is safe and effective in treating marginal corneal infiltrates.
What is the current status of trial NCT00579020?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 144 participants. The study started on 2007-12. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00579020?
The interventions under investigation include: Moxifloxacin/dexamethasone phosphate ophthalmic solution (DRUG), Moxifloxacin ophthalmic solution 0.5% (DRUG), Dexamethasone phosphate solution, 0.1% (DRUG).
Who is sponsoring clinical trial NCT00579020?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00579020's enrollment target sits among peer trials
144 500th of 2000 higher than 1,494 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia